Please login to the form below

lung conditions

This page shows the latest lung conditions news and features for those working in and with pharma, biotech and healthcare.

Roche’s flu pill Xofluza gains EU approval

This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.

Latest news

Roche’s flu pill Xofluza moves closer towards EU approval

This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
Gilead’s remdesivir not included in WHO’s COVID-19 drug scheme

According to Reuters, the draft document prioritises monoclonal antibodies to treat COVID-19, as well as procuring doses of dexamethasone, a steroid originally used to treat a number of conditions including ... rheumatic problems and obstructive lung
Roche scores another FDA approval for Xofluza

It can now add that it is the first and only antiviral medicine indicated for high-risk patients, such as those who have conditions including asthma, chronic lung disease, diabetes, heart ... Levi Garraway. “People with chronic conditions such as asthma
Encouraging data for Roche flu drug ahead of FDA decision

65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.
Regional NHS pulmonary rehabilitation video campaign launched

A video campaign to promote the health and lifestyle benefits of pulmonary rehabilitation for those with long-term lung conditions has been launched across the north east of England. ... AHSN NENC collaborated on the campaign with the British Lung

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

PulmoBioMed Wins National Life Science Competition

The device allows sampling of the lungs in a non-invasive way which can be used to detect biomarkers in the breath, for lung conditions such as COVID-19, therapeutic drugs
Newcells Biotech secures over £5m for 3D tissue models

The seven-figure investment will accelerate the development of models for liver and lung conditions, the latter of which could advance the research into SARS-CoV-2 and its treatments.
October 2020: diversity and inclusion in clinical trials round-up

People with chronic conditions such as diabetes, lung disease, and heart disease, and those of advanced age, had a poorer prognosis once infected with COVID-19. ... In the U.S., these chronic conditions disproportionately affect minority populations,
What impact do GPs think the new NHS cancer guide will have?

The guidelines empower GPs to fully investigate patients presenting with symptoms that could be linked to conditions such as myeloma, lung cancer and ovarian cancer, without the need for secondary care ... referral. These conditions often first present

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password:

Please login to the form below

lung conditions

Subscribe to our email news alerts

Quick links